Plasma phospholipids transfer protein (PLTP) is a member of the lipid transfer/lipopolysaccharide binding protein gene family. PLTP is involved in the metabolism of high density lipoprotein (HDL) and apolipoprotein B (apoB)-containing lipoproteins. PLTP is an independent risk factor for coronary artery disease. In mouse models, it has been demonstrated that PLTP deficiency reduces atherosclerosis while its overexpression shows the opposite effect. Therefore, PLTP is considered a promising target for pharmacological interventions on atherosclerosis. However, this possibility is hampered by the fact that the substance's atherogenic mechanism is not completely understood. PLTP is a protein with multiple functions and expressed in various tissues. In order to unravel the complex mechanisms involved, we will use the transgenic and knockout mouse models generated in my and other laboratories, to test our general hypothesis that PLTP has proatherogenic properties.
The Specific Aims are: 1) to evaluate the hypothesis that PLTP overexpression and PLTP deficiency represent two distinct states in HDL metabolism and function;2) to investigate the effect of tissue-specific PLTP overexpression on lipoprotein metabolism and atherosclerosis;and 3) to determine the effect of tissue-specific PLTP deficiency on lipoprotein metabolism and atherosclerosis. This project will provide new information on the relationship between PLTP activity and lipoprotein metabolism, between PLTP activity and atherosclerosis, and will provide biochemical basis for further evaluation of PLTP as a therapeutic target.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069817-08
Application #
7784430
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Liu, Lijuan
Project Start
2002-04-15
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
8
Fiscal Year
2010
Total Cost
$351,000
Indirect Cost
Name
Suny Downstate Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
040796328
City
Brooklyn
State
NY
Country
United States
Zip Code
11203
Li, Zhiqiang; Jiang, Hui; Ding, Tingbo et al. (2015) Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice. Gastroenterology 149:1519-29
Jiang, Hui; Yazdanyar, Amirfarbod; Lou, Bin et al. (2015) Adipocyte phospholipid transfer protein and lipoprotein metabolism. Arterioscler Thromb Vasc Biol 35:316-22
Yazdanyar, Amirfarbod; Quan, Wei; Jin, Weijun et al. (2013) Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice. Arterioscler Thromb Vasc Biol 33:2058-64
Chakraborty, Mahua; Jiang, Xian-Cheng (2013) Sphingomyelin and its role in cellular signaling. Adv Exp Med Biol 991:1-14
Li, Yue; Dong, Jibin; Ding, Tingbo et al. (2013) Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor ?2 suppression. Arterioscler Thromb Vasc Biol 33:1513-20
Yazdanyar, Amirfarbod; Jiang, Xian-Cheng (2012) Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice. Hepatology 56:576-84
Luo, Yi; Shelly, Lorraine; Sand, Thomas et al. (2010) Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes. J Pharmacol Exp Ther 332:1100-6
Yeang, Calvin; Qin, Shucun; Chen, Kailian et al. (2010) Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism. J Lipid Res 51:2993-3002
Schlitt, Axel; Schwaab, Bernhard; Fingscheidt, Kirsten et al. (2010) Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes. Lipids 45:129-35
Luo, Yi; Shelly, Lorraine; Sand, Thomas et al. (2010) Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein. J Pharmacol Exp Ther 335:653-8

Showing the most recent 10 out of 36 publications